Cenobamate als Medikament in Härtefallprogramm (CUP) für die Behandlung von arzneimittelresistenten fokal beginnenden Anfällen bei Erwachsenen aufgenommen
September 14, 2020 01:00 ET
|
Arvelle Therapeutics
Cenobamate erreicht die Zulassung des Bundesinstituts für Arzneimittel und Medizinprodukte (BfArM) zum Arzneimittel-Härtefallprogramm für ein Jahr In Großbritannien wird cenobamate als...
Artificial Intelligence (AI) in Drug Discovery Market Size, Share 2020-2027: Industry Analysis by CAGR of 40.5%, Growth & Opportunities, Upcoming Trends, Latest Innovation by Microsoft, IBM, NVIDIA, Cloud Pharmaceuticals
September 07, 2020 15:24 ET
|
Data Bridge Market Research
SAN FRANCISCO, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Drug Discovery Market Size" Study has been added to DBMR database. This report consists of information about...
Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing
July 27, 2020 12:10 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment
July 22, 2020 08:30 ET
|
Quince Market Insights
Pune, India, July 22, 2020 (GLOBE NEWSWIRE) -- Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period....
Immunosuppressant Market Expected to Reach $42,511 Mn by 2026 at 14.7% CAGR : AMR
June 29, 2020 11:49 ET
|
Allied Market Research
Portland, OR, June 29, 2020 (GLOBE NEWSWIRE) -- According to the report, the global immunosuppressants market was estimated at $13.89 billion in 2018 and is expected to hit $42.51 billion by 2026,...
OTC Drugs See Rising Interest as a Result of the Coronavirus Pandemic - ResearchAndMarkets.com
April 06, 2020 12:28 ET
|
Research and Markets
DUBLIN, Ireland, April 06, 2020 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com identifies Over-the-counter Drugs as one of the key industries seeing increased demand due to the Coronavirus pandemic. ...
首个抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动
April 06, 2020 07:00 ET
|
Yiviva
—— 利用整合系统生物学方法，由耶鲁大学郑永齐教授和医起共同开发的首个抗肿瘤候选植物药 中国上海，美国纽约, April 06, 2020 (GLOBE NEWSWIRE) -- 生物制药创新企业医起医药科技有限公司（Yiviva Inc.），在2020年初正式启动了YIV-906联合索拉非尼治疗乙型肝炎相关性肝细胞癌（HCC）的一线疗法IIb期研究，并于今年三月迎来了第一位受试者。 ...
Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma
April 06, 2020 07:00 ET
|
Yiviva
- First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach -- Global study to evaluate efficacy, safety, and quality of life in patients with hepatitis...
US importation is a catastrophic threat to the Canadian drug supply: two new studies advise urgent action from Canada’s federal government
September 24, 2019 08:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Two new studies published in the journal Canadian Health Policy, conclude that the Canadian federal government must act swiftly and preemptively to stop...
Drug Eluting Stent Market To Reach USD 8.74 Billion By 2026 | Reports And Data
September 03, 2019 10:53 ET
|
Reports and Data
New York, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Rise in the public health awareness and increased government funding in medical sector with cardiac treatment centers, supportive regulatory environment...